Back to search
FDAFDA · Food and drugs·Recall number D-839-2013

VersaPharm Incorporated, Ethambutol Hydrochloride Tablets, USP 400 mg 60 tablets, Rx Only, Mfd. for VersaPharm Incorporated Marietta, GA 30065-1509; Mfd. by: West-ward Pharmaceuticals Corp., Eatontown, NJ 07724 NDC 61748-014-06,

Published August 14, 2013 · Recall initiated: June 4, 2013

Summary

FDA records drug Class II recall D-839-2013, published August 14, 2013 and initiated June 4, 2013. Recalling firm: West-Ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: 118 bottles; Lot: Lot 69968B 03/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description testing for a surface defect of ink.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
West-Ward Pharmaceutical Corp.
Distributor
GA
Lot
Lot 69968B 03/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was VersaPharm Incorporated, Ethambutol Hydrochloride Tablets, USP 400 mg 60 tablets, Rx Only, Mfd. for VersaPharm Incorporated Marietta, GA 30065-1509; Mfd. by: West-ward Pharmaceuticals Corp., Eatontown, NJ 07724 NDC 61748-014-06, recalled?

Yes. FDA published recall D-839-2013 on August 14, 2013. Reported hazard: Discoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description testing for a surface defect of ink.

What should I do if I have this product?

Voluntary: Firm initiated · Letter